Ivor Elrifi - 18 Mar 2026 Form 3 Insider Report for Tiziana Life Sciences Ltd (TLSA)

Reporting relationship
CHIEF EXECUTIVE OFFICER, Director
Issuer ticker
TLSA
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
23 Jul 2026, 16:20:32 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ivor Elrifi

Key filing fact

Ivor Elrifi filed Form 3 for Tiziana Life Sciences Ltd (TLSA) on 23 Jul 2026.

Key facts

  • This page summarizes Ivor Elrifi's Form 3 filing for Tiziana Life Sciences Ltd (TLSA).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Jul 2026, 16:20.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002136241 Primary reporting owner

Elrifi Ivor

Relationship
CHIEF EXECUTIVE OFFICER, Director
Address
C/O TIZIANA LIFE SCIENCES LTD, 14-15 CONDUIT STREET, LONDON, UNITED KINGDOM
Signature
/s/ Ivor Elrifi
Signature date
23 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSA holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,805,261
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLSA holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
common stock
Underlying amount
3,150,000
Exercise price
$1.26
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

1,050,000 RSU's will vest annually over 3 years

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .